{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:16:35Z","timestamp":1784715395214,"version":"3.55.0"},"reference-count":227,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Calcific aortic valve disease (CAVD) is a progressive disease, of which the 2-year mortality is &amp;gt;50% for symptomatic aortic valve stenosis unless transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) is performed promptly. The prevalence of diabetes among CAVD has increased rapidly in recent years. The combination of diabetes with its cardio-renal and metabolic comorbidities, such as hypertension, hyperlipidemia, chronic kidney disease, and ageing, accelerated the progression of CAVD and increased the subsequent needs for aortic valve replacement. Clinical data regarding the impact of diabetes on outcomes of patients undergoing TAVR or SAVR have exhibited inconsistent results. Compared with non-diabetes, the short-term mortality after TAVR was not significant in diabetes, while the mid-term mortality differed from different cohorts. Although there were worse mid-term and long-term mortalities after SAVR in diabetes, the short-term mortality in diabetes was disputable. As for complications, there were common worse manifestations with coronary heart disease, acute kidney injury, heart failure, and systemic inflammatory response syndrome in diabetes undergoing TAVR or SAVR. Moreover, diabetes was one of the risk factors for deterioration of bioprosthetic aortic valves, leading to increased long-term mortality. Based on the efficacy for CAVD and atherosclerotic cardiovascular disease, glucose-lowering medications might have potential to inhibit deterioration of bioprosthetic aortic valves independent of glucose control.<\/jats:p>","DOI":"10.3389\/fendo.2025.1577762","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T04:13:19Z","timestamp":1753848799000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Diabetes and calcific aortic valve disease: controversy of clinical outcomes in diabetes after aortic valve replacement"],"prefix":"10.3389","volume":"16","author":[{"given":"Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis\u2013from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jacc.2022.05.006","article-title":"Evolution and prognostic impact of cardiac damage after aortic valve replacement","volume":"80","author":"G\u00e9n\u00e9reux","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1910555","article-title":"Five-year outcomes of transcatheter or surgical aortic-valve replacement","volume":"382","author":"Makkar","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.110.006767","article-title":"Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update","volume":"124","author":"Rajamannan","year":"2011","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.025","article-title":"Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study","volume":"69","author":"Yan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.109.900027","article-title":"Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192","article-title":"ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.10.001","article-title":"Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis","volume":"66","author":"Taniguchi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx001","article-title":"Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study","volume":"38","author":"Singh","year":"2017","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2017.10.057","article-title":"Trends in aortic valve replacement procedures between 2009 and 2015: has transcatheter aortic valve replacement made a difference","volume":"105","author":"Culler","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12933-018-0780-2","article-title":"Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001-2015)","volume":"17","author":"L\u00f3pez-de-Andr\u00e9s","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jtcvs.2021.04.064","article-title":"Outcomes of surgical aortic valve replacement over three decades","volume":"164","author":"\u00c7elik","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.844068","article-title":"Trends and outcomes of aortic valve replacement in patients with diabetes in the US","volume":"9","author":"Khan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00845-7","article-title":"Calcific aortic valve disease: mechanisms, prevention and treatment","volume":"20","author":"Moncla","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/atvbaha.119.313067","article-title":"Aortic valve stenosis: from basic mechanisms to novel therapeutic targets","volume":"40","author":"Goody","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.064","article-title":"Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study","volume":"50","author":"Novaro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-017-0609-4","article-title":"Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014)","volume":"16","author":"de Miguel-Yanes","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22723","article-title":"Diabetes mellitus is associated with increased acute kidney injury and 1-year mortality after transcatheter aortic valve replacement: A meta-analysis","volume":"40","author":"Mina","year":"2017","journal-title":"Clin Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12933-015-0291-3","article-title":"Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement","volume":"14","author":"Berkovitch","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.116.005133","article-title":"Traditional cardiovascular risk factors and their relation to future surgery for valvular heart disease or ascending aortic disease: A case-referent study","author":"Ljungberg","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2021.09.010","article-title":"Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: A nationwide study","volume":"243","author":"Strange","year":"2022","journal-title":"Am Heart J"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/14017431.2024.2353070","article-title":"Hyperglycemia-simulating environment attenuated experimentally induced calcification in cultured human aortic valve interstitial cells","volume":"58","author":"Zabirnyk","year":"2024","journal-title":"Scand Cardiovasc J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/polym12122786","article-title":"Chronic high glucose concentration induces inflammatory and remodeling changes in valvular endothelial cells and valvular interstitial cells in a gelatin methacrylate 3D model of the human aortic valve","volume":"12","author":"Ciortan","year":"2020","journal-title":"Polymers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136976","article-title":"Crosstalk of diabetic conditions with static versus dynamic flow environment-impact on aortic valve remodeling","volume":"22","author":"Selig","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.carpath.2018.02.002","article-title":"Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr(-\/-)ApoB(100\/100) mouse model","volume":"34","author":"Scatena","year":"2018","journal-title":"Cardiovasc Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-012-0306-0","article-title":"Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products","volume":"107","author":"Li","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05545-w","article-title":"Diabetes concomitant to aortic stenosis is associated with increased expression of NF-\u03baB and more pronounced valve calcification","volume":"64","author":"Kopytek","year":"2021","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","article-title":"Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes","volume":"19","author":"Kopytek","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exger.2014.05.001","article-title":"RAGE influences the development of aortic valve stenosis in mice on a high fat diet","volume":"59","author":"Hofmann","year":"2014","journal-title":"Exp Gerontol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.12.012","article-title":"RAGE deficiency alleviates aortic valve calcification in ApoE(-\/-) mice via the inhibition of endoplasmic reticulum stress","volume":"1863","author":"Wang","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2017.21","article-title":"Association between changes in systolic blood pressure and incident diabetes in a community-based cohort study in Korea","volume":"40","author":"Lee","year":"2017","journal-title":"Hypertens Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-018-0034-4","article-title":"Hypertension with diabetes mellitus: physiology and pathology","volume":"41","author":"Ohishi","year":"2018","journal-title":"Hypertens Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/08037050701343241","article-title":"Severe aortic stenosis and its association with hypertension: analysis of clinical and echocardiographic parameters","volume":"16","author":"Linhartov\u00e1","year":"2007","journal-title":"Blood Press"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy486","article-title":"Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults","volume":"39","author":"Rahimi","year":"2018","journal-title":"Eur Heart J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.041749","article-title":"The effects of hypertension on aortic valve stenosis","volume":"91","author":"Bermejo","year":"2005","journal-title":"Heart"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.113.005275","article-title":"Time to treat hypertension in patients with aortic stenosis","volume":"128","author":"Lindman","year":"2013","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1101\/gad.276304","article-title":"Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation","volume":"18","author":"Timmerman","year":"2004","journal-title":"Genes Dev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235553","article-title":"Arterial hypertension in aortic valve stenosis: A critical update","volume":"10","author":"Basile","year":"2021","journal-title":"J Clin Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(03)00284-3","article-title":"Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis","volume":"170","author":"Kaden","year":"2003","journal-title":"Atherosclerosis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/s0735-1097(01)01705-3","article-title":"Progression of human aortic valve stenosis is associated with tenascin-C expression","volume":"39","author":"Satta","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bone.2019.04.006","article-title":"IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2","volume":"124","author":"Kurozumi","year":"2019","journal-title":"Bone"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.122.321889","article-title":"Non-canonical TERT activity initiates osteogenesis in calcific aortic valve disease","volume":"136","author":"Cuevas","year":"2025","journal-title":"Circ Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.11.026","article-title":"Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET\/CT study","volume":"238","author":"Abdelbaky","year":"2015","journal-title":"Atherosclerosis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad142","article-title":"Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study","volume":"44","author":"Yu Chen","year":"2023","journal-title":"Eur Heart J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa070","article-title":"Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study","volume":"41","author":"Nazarzadeh","year":"2020","journal-title":"Eur Heart J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.17.4.680","article-title":"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients","volume":"17","author":"Parhami","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328308b622","article-title":"The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity","volume":"19","author":"Tsimikas","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2007.125740","article-title":"Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis","volume":"94","author":"C\u00f4t\u00e9","year":"2008","journal-title":"Heart"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que","year":"2018","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e93230","DOI":"10.1371\/journal.pone.0093230","article-title":"A novel highly potent autotaxin\/ENPP2 inhibitor produces prolonged decreases in plasma lysophosphatidic acid formation in vivo and regulates urethral tension","volume":"9","author":"Saga","year":"2014","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2017.02.004","article-title":"Lipoprotein(a) associated molecules are prominent components in plasma and valve leaflets in calcific aortic valve stenosis","volume":"2","author":"Torzewski","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx089","article-title":"OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-\u03baB pathway","volume":"113","author":"Nsaibia","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","article-title":"An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines","author":"Selby","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic valve calcification in chronic kidney disease","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.08.009","article-title":"Prevalence and prognostic implications of mitral and aortic valve calcium in patients with chronic kidney disease","volume":"122","author":"Hensen","year":"2018","journal-title":"Am J Cardiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.006044","article-title":"Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease","volume":"6","author":"Samad","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.114.302523","article-title":"Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease","volume":"34","author":"Yutzey","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13062-023-00390-w","article-title":"Single-cell transcriptomics reveals cellular heterogeneity and macrophage-to-mesenchymal transition in bicuspid calcific aortic valve disease","volume":"18","author":"Lyu","year":"2023","journal-title":"Biol Direct"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2017.07.016","article-title":"Mast cells in calcific aortic stenosis","volume":"214","author":"\u0160teiner","year":"2018","journal-title":"Pathol Res Pract"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.109.201749","article-title":"Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB\/c mice","volume":"30","author":"Isoda","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.87.11.1055","article-title":"Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies","volume":"87","author":"Proudfoot","year":"2000","journal-title":"Circ Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-012-9579-6","article-title":"Inflammation is associated with the remodeling of calcific aortic valve disease","volume":"36","author":"Cot\u00e9","year":"2013","journal-title":"Inflammation"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.07.054","article-title":"Induction of local angiotensin II-producing systems in stenotic aortic valves","volume":"44","author":"Helske","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0008-6363(96)88547-6","article-title":"Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart","volume":"29","author":"Katwa","year":"1995","journal-title":"Cardiovasc Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.10.055","article-title":"Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice","volume":"226","author":"Fujisaka","year":"2013","journal-title":"Atherosclerosis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"Jama"},{"key":"B73","article-title":"Aging changes in the aortic and mitral valves. Histologic and histochemical studies, with observations on the pathogenesis of calcific aortic stenosis and calcification of the mitral annulus","volume":"46","author":"Sell","year":"1965","journal-title":"Am J Pathol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960110802","article-title":"The old-age heart: normal aging changes which can produce or mimic cardiac disease","volume":"11","author":"Waller","year":"1988","journal-title":"Clin Cardiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00570-z","article-title":"Global epidemiology of valvular heart disease","volume":"18","author":"Coffey","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms161025234","article-title":"Diabetic cardiovascular disease induced by oxidative stress","volume":"16","author":"Kayama","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/circresaha.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e0123257","DOI":"10.1371\/journal.pone.0123257","article-title":"Endothelial-derived oxidative stress drives myofibroblastic activation and calcification of the aortic valve","volume":"10","author":"Farrar","year":"2015","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacbts.2019.10.004","article-title":"Celastrol alleviates aortic valve calcification via inhibition of NADPH oxidase 2 in valvular interstitial cells","volume":"5","author":"Liu","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1161\/atvbaha.112.300794","article-title":"Pioglitazone attenuates valvular calcification induced by hypercholesterolemia","volume":"33","author":"Chu","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2018.05.019","article-title":"Mitochondrial uncoupling, ROS generation and cardioprotection","volume":"1859","author":"Cadenas","year":"2018","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"B82","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jacbts.2022.03.002","article-title":"PTP1B inhibition improves mitochondrial dynamics to alleviate calcific aortic valve disease via regulating OPA1 homeostasis","volume":"7","author":"Liu","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.025","article-title":"Pathological significance of lipoprotein(a) in aortic valve stenosis","volume":"272","author":"Yu","year":"2018","journal-title":"Atherosclerosis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab757","article-title":"Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur Heart J"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.14423\/smj.0000000000001516","article-title":"Hypertension in chronic kidney disease: an update on diagnosis and management","volume":"116","author":"Gupta","year":"2023","journal-title":"South Med J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1172\/jci165654","article-title":"Molecular pathways that drive diabetic kidney disease","volume":"133","author":"Mohandes","year":"2023","journal-title":"J Clin Invest"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097898","article-title":"Mechanisms of oxidative stress in metabolic syndrome","volume":"24","author":"Masenga","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2534","article-title":"Guideline update on indications for transcatheter aortic valve implantation based on the 2020 american college of cardiology\/american heart association guidelines for management of valvular heart disease","volume":"6","author":"Sundt","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"E1058","DOI":"10.1002\/ccd.29960","article-title":"Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry","volume":"98","author":"Matsumoto","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B90","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12933-019-0873-6","article-title":"The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry","volume":"18","author":"Tzamalis","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1161\/circinterventions.117.005417","article-title":"Clinical impact of diabetes mellitus on outcomes after transcatheter aortic valve replacement: insights from the society of thoracic surgeons\/american college of cardiology transcatheter valve therapy registry","author":"Abramowitz","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.08.035","article-title":"Impact of diabetes mellitus on female subjects undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI international registry","volume":"322","author":"Goel","year":"2021","journal-title":"Int J Cardiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.057","article-title":"Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve)","volume":"63","author":"Lindman","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12933-017-0631-6","article-title":"Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014-2015)","volume":"16","author":"Mendez-Bailon","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.4244\/eij-d-17-00421","article-title":"TAVI risk scoring using established versus new scoring systems: role of the new STS\/ACC model","volume":"13","author":"Arsalan","year":"2018","journal-title":"EuroIntervention"},{"key":"B96","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s1010-7940(99)00134-7","article-title":"European system for cardiac operative risk evaluation (EuroSCORE)","volume":"16","author":"Nashef","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"B98","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12933-022-01654-x","article-title":"Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis","volume":"21","author":"van Nieuwkerk","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.09.032","article-title":"Impact of diabetes mellitus and hemoglobin A1C on outcome after transcatheter aortic valve implantation","volume":"116","author":"Chorin","year":"2015","journal-title":"Am J Cardiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2660","article-title":"Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio","volume":"100","author":"Roberts","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B101","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12933-024-02160-y","article-title":"Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study","volume":"23","author":"Hu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00392-018-1309-0","article-title":"Gender-dependent association of diabetes mellitus with mortality in patients undergoing transcatheter aortic valve replacement","volume":"108","author":"Linke","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2017.08.002","article-title":"Effect of diabetes mellitus on clinical outcomes and quality of life after transcatheter aortic valve implantation for severe aortic valve stenosis","volume":"59","author":"Tokarek","year":"2018","journal-title":"Hellenic J Cardiol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2020.05.008","article-title":"Comparison of clinical and echocardiographic features of asymptomatic patients with stenotic bicuspid versus tricuspid aortic valves","volume":"128","author":"Sia","year":"2020","journal-title":"Am J Cardiol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-019-00155-5","article-title":"Comparative outcomes of transapical versus transfemoral access for transcatheter aortic valve replacement in diabetics","volume":"9","author":"Elbadawi","year":"2020","journal-title":"Cardiol Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.12.062","article-title":"Balloon dilatation and outcome among patients undergoing trans-femoral aortic valve replacement","volume":"230","author":"Fink","year":"2017","journal-title":"Int J Cardiol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01928-6","article-title":"In-hospital outcomes of self-expanding and balloon-expandable transcatheter heart valves in Germany","volume":"110","author":"Stachon","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02326-w","article-title":"Comparing balloon-expandable and self-expanding transfemoral transcatheter aortic valve replacement based on subgroups in Germany 2019\/2020","volume":"113","author":"Oettinger","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900\u2013000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.03.018","article-title":"Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry","volume":"3","author":"Lancefield","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp317","article-title":"Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention","volume":"31","author":"Hastie","year":"2010","journal-title":"Eur Heart J"},{"key":"B112","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pcad.2022.12.006","article-title":"Effect of BMI on patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis","volume":"78","author":"Gupta","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"B113","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amjcard.2020.09.039","article-title":"Long-term outcomes stratified by body mass index in patients undergoing transcatheter aortic valve implantation","volume":"137","author":"Quine","year":"2020","journal-title":"Am J Cardiol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02098-3","article-title":"Obesity paradox in transcatheter aortic valve replacement","volume":"26","author":"Madanat","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11060169","article-title":"Obesity and transcatheter aortic valve replacement","volume":"11","author":"Seo","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.06.012","article-title":"Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"74","author":"Faroux","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B117","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5223(19)35524-2","article-title":"The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis","volume":"100","author":"Lund","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2023.09.023","article-title":"Aortic stenosis with coronary artery disease: SAVR or TAVR-when and how","volume":"40","author":"Del Portillo","year":"2024","journal-title":"Can J Cardiol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/mca.0000000000001386","article-title":"Impact of prior coronary artery bypass grafting and coronary lesion complexity on outcomes of transcatheter aortic valve replacement for severe aortic stenosis","author":"Yamashita","year":"2024","journal-title":"Coron Artery Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.07.009","article-title":"Procedural characteristics and late outcomes of percutaneous coronary intervention in the workup pre-TAVR","volume":"13","author":"Faroux","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e012417","DOI":"10.1161\/circinterventions.122.012417","article-title":"Management of myocardial revascularization in patients with stable coronary artery disease undergoing transcatheter aortic valve implantation","volume":"15","author":"Costa","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.05.007","article-title":"Feasibility of coronary access in patients with acute coronary syndrome and previous TAVR","volume":"14","author":"Kim","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.11.027","article-title":"Incidence and outcomes of acute coronary syndrome after transcatheter aortic valve replacement","volume":"13","author":"Mentias","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2000431","article-title":"Kidney function change after transcatheter aortic valve replacement in patients with diabetes and\/or hypertension","volume":"22","author":"Fan","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.11.024","article-title":"Acute kidney recovery in patients who underwent transcatheter versus surgical aortic valve replacement (from the northern new england cardiovascular disease study group)","volume":"125","author":"Lahoud","year":"2020","journal-title":"Am J Cardiol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e019930","DOI":"10.1161\/jaha.120.019930","article-title":"Long-term outcomes of transcatheter aortic valve replacement in patients with end-stage renal disease","volume":"10","author":"Ogami","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e032955","DOI":"10.1161\/jaha.123.032955","article-title":"Risk score for prediction of dialysis after transcatheter aortic valve replacement","volume":"13","author":"Pasceri","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e0276394","DOI":"10.1371\/journal.pone.0276394","article-title":"Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease","volume":"17","author":"Park","year":"2022","journal-title":"PloS One"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.1666","article-title":"Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial","volume":"64","author":"Svensson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.027","article-title":"Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death","volume":"65","author":"Urena","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2023.07.015","article-title":"Cardiac death after transcatheter aortic valve replacement with contemporary devices","volume":"16","author":"Mesnier","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz891","article-title":"Sudden cardiac death among persons with diabetes aged 1\u201349 years: a 10-year nationwide study of 14\u2009294 deaths in Denmark","volume":"41","author":"Lynge","year":"2020","journal-title":"Eur Heart J"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e008959","DOI":"10.1161\/circinterventions.120.008959","article-title":"Determinants and impact of heart failure readmission following transcatheter aortic valve replacement","volume":"13","author":"Auffret","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0282","article-title":"Epidemiology, pathophysiology, diagnosis and treatment of heart failure in diabetes","volume":"45","author":"Park","year":"2021","journal-title":"Diabetes Metab J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.122.063444","article-title":"Association between type 2 diabetes and changes in myocardial structure, contractile function, energetics, and blood flow before and after aortic valve replacement in patients with severe aortic stenosis","volume":"148","author":"Jex","year":"2023","journal-title":"Circulation"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.2222","article-title":"Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-year clinical outcomes","volume":"7","author":"Kolte","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-002015","article-title":"Impact of elevated left ventricular filling pressure on long-term outcomes after transcatheter aortic valve replacement","volume":"9","author":"Nair","year":"2022","journal-title":"Open Heart"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2021.08.068","article-title":"Incidence, predictive factors, and prognostic impact of right ventricular dysfunction before transcatheter aortic valve implantation","volume":"161","author":"Durand","year":"2021","journal-title":"Am J Cardiol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.amjcard.2020.06.033","article-title":"Impact of loop diuretic use on outcomes following transcatheter aortic valve implantation","volume":"131","author":"Cantey","year":"2020","journal-title":"Am J Cardiol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101428","article-title":"Causes and determinants of heart failure readmissions post transcutaneous aortic valve replacement: A systematic review and meta-analysis","volume":"48","author":"Yasmin","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.2172","article-title":"Stroke after surgical versus transfemoral transcatheter aortic valve replacement in the PARTNER trial","volume":"72","author":"Kapadia","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26612","article-title":"Incidence and clinical impact of stroke complicating transcatheter aortic valve implantation: results from the german TAVI registry","volume":"88","author":"Werner","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"B143","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.1038\/s41598-021-89217-0","article-title":"Late stroke after transcatheter aortic valve replacement: a nationwide study","volume":"11","author":"Bjursten","year":"2021","journal-title":"Sci Rep"},{"key":"B144","doi-asserted-by":"publisher","first-page":"e010920","DOI":"10.1161\/jaha.118.010920","article-title":"Silent brain infarcts following cardiac procedures: A systematic review and meta-analysis","volume":"8","author":"Indja","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab002","article-title":"Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"42","author":"Woldendorp","year":"2021","journal-title":"Eur Heart J"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jez256","article-title":"Subclinical leaflet thrombosis is associated with impaired reverse remodelling after transcatheter aortic valve implantation","volume":"21","author":"Szilveszter","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.035","article-title":"Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve","volume":"60","author":"Urena","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02160-0","article-title":"Prediction of conduction disturbances in patients undergoing transcatheter aortic valve replacement","volume":"112","author":"Pavlicek","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v16.i3.104","article-title":"Predictors of permanent pacemaker implantation following transcatheter aortic valve replacement-the search is still on","volume":"16","author":"Prajapathi","year":"2024","journal-title":"World J Cardiol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v15.i11.582","article-title":"Novel predictors of permanent pacemaker implantation following transcatheter aortic valve replacement","volume":"15","author":"Nwaedozie","year":"2023","journal-title":"World J Cardiol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-021-01039-2","article-title":"Incidence, predictors, and clinical outcomes of permanent pacemaker insertion following transcatheter aortic valve implantation in an Arab population","volume":"63","author":"Rajah","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.4244\/eijy14m06_05","article-title":"Occurrence and prognostic impact of systemic inflammatory response syndrome in transfemoral and transapical aortic valve implantation with balloon- and self-expandable valves","volume":"10","author":"Schwietz","year":"2015","journal-title":"EuroIntervention"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-307057","article-title":"Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement","volume":"101","author":"Lindman","year":"2015","journal-title":"Heart"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs002","article-title":"Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation","volume":"33","author":"Sinning","year":"2012","journal-title":"Eur Heart J"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12837","article-title":"Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation","volume":"7","author":"Hoffmann","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/life13010054","article-title":"Elevated fasting glucose and C-reactive protein levels predict increased all-cause mortality after elective transcatheter aortic valve implantation","author":"Dekany","year":"2022","journal-title":"Life (Basel)"},{"key":"B157","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-023-01763-1","article-title":"Systemic proinflammatory-profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome","volume":"22","author":"Lee","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"E172","DOI":"10.1002\/ccd.28989","article-title":"Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease","volume":"97","author":"Li","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.4244\/eij-d-21-01048","article-title":"Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2","volume":"18","author":"Garot","year":"2022","journal-title":"EuroIntervention"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.09.063","article-title":"Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial","volume":"297","author":"Goel","year":"2019","journal-title":"Int J Cardiol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezab499","article-title":"Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact","volume":"61","author":"Lunardi","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000001075","article-title":"Impact of comorbidities and antiplatelet regimen on platelet reactivity levels in patients undergoing transcatheter aortic valve implantation","volume":"78","author":"Trejo-Velasco","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"key":"B164","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jtcvs.2011.04.048","article-title":"Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use\u2013an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database","volume":"142","author":"Dunning","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B165","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12933-019-0836-y","article-title":"Type 2 diabetes mellitus increases long-term mortality risk after isolated surgical aortic valve replacement","volume":"18","author":"Ram","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12933-015-0300-6","article-title":"Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"14","author":"Bundhun","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.022","article-title":"Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox","volume":"63","author":"Lavie","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.117.026856","article-title":"An apparent obesity paradox in cardiac surgery","volume":"135","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e12506","DOI":"10.1111\/cob.12506","article-title":"Heart valve surgery and the obesity paradox: A systematic review","volume":"12","author":"El-Andari","year":"2022","journal-title":"Clin Obes"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144841","article-title":"Long-Term Survival among Octogenarians Undergoing Aortic Valve Replacement with or without Simultaneous Coronary Artery Bypass Grafting: A 22-Year Tertiary Single-Center Experience","author":"Masraf","year":"2023","journal-title":"J Clin Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-022-02073-4","article-title":"The early and long-term outcomes of coronary artery bypass grafting added to aortic valve replacement compared to isolated aortic valve replacement in elderly patients: a systematic review and meta-analysis","volume":"37","author":"D\u2019Alessandro","year":"2022","journal-title":"Heart Vessels"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-018-1053-4","article-title":"Outcomes after aortic valve replacement for aortic valve stenosis, with or without concomitant coronary artery bypass grafting","volume":"67","author":"Sakakura","year":"2019","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14847","article-title":"Male-female differences following concomitant coronary artery bypass grafting and aortic valve replacement surgery","author":"Krey","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B174","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/eurheartj\/ehab445","article-title":"Is there equivalence between PCI and CABG surgery in long-term survival of patients with diabetes? Importance of interpretation biases and biological plausibility","volume":"43","author":"Boden","year":"2021","journal-title":"Eur Heart J"},{"key":"B175","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/eurheartj\/ehab441","article-title":"Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease","volume":"43","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e052340","DOI":"10.1136\/bmjopen-2021-052340","article-title":"Efficacy of a glucagon-like peptide-1 agonist and restrictive versus liberal oxygen supply in patients undergoing coronary artery bypass grafting or aortic valve replacement: study protocol for a 2-by-2 factorial designed, randomised clinical trial","volume":"11","author":"Wiberg","year":"2021","journal-title":"BMJ Open"},{"key":"B177","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1055\/s-0040-1710318","article-title":"Predictors of acute kidney injury following surgical valve replacement","volume":"69","author":"Ibrahim","year":"2021","journal-title":"Thorac Cardiovasc Surg"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2004.05.021","article-title":"The incidence and risk of acute renal failure after cardiac surgery","volume":"18","author":"Bove","year":"2004","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2019.07.052","article-title":"Risk analysis and outcomes of postoperative renal failure after aortic valve surgery in the United States","volume":"109","author":"Caceres Polo","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.10.042","article-title":"Recovery of kidney dysfunction after transcatheter aortic valve implantation (from the northern new england cardiovascular disease study group)","volume":"123","author":"Azarbal","year":"2019","journal-title":"Am J Cardiol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2021.05.019","article-title":"Outcomes in patients with chronic renal failure on hemodialysis after aortic valve or root replacement","volume":"34","author":"Malik","year":"2022","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01717-7","article-title":"Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis","volume":"110","author":"F\u00e4rber","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2018.09.015","article-title":"Impact of metabolic syndrome and\/or diabetes mellitus on left ventricular mass and remodeling in patients with aortic stenosis before and after aortic valve replacement","volume":"123","author":"Guzzetti","year":"2019","journal-title":"Am J Cardiol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14887","article-title":"Heart failure hospitalization following surgical or transcatheter aortic valve implantation in low-risk aortic stenosis","author":"L\u00f3pez-Mart\u00ednez","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases","author":"Seferovi\u0107","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.778886","article-title":"Prosthetic heart valves: selection of the optimal prosthesis and long-term management","volume":"119","author":"Pibarot","year":"2009","journal-title":"Circulation"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezt245","article-title":"Indexed effective orifice area is a significant predictor of higher mid- and long-term mortality rates following aortic valve replacement in patients with prosthesis-patient mismatch","volume":"45","author":"Chen","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.10.026","article-title":"Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement","volume":"9","author":"Dayan","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-313515","article-title":"Patient-prosthesis mismatch following aortic valve replacement","author":"Bilkhu","year":"2019","journal-title":"Heart"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.15658","article-title":"Patient-prosthesis mismatch and surgical aortic valve replacement outcomes: Retrospective analysis of single-center surgical data","volume":"36","author":"Gupta","year":"2021","journal-title":"J Card Surg"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2024.05.025","article-title":"Impact of patient-prosthesis mismatch on long-term outcomes after aortic valve replacement","author":"Graser","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae043","article-title":"Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial","volume":"45","author":"Thyregod","year":"2024","journal-title":"Eur Heart J"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.119.041399","article-title":"Prosthetic valve endocarditis after TAVR and SAVR: insights from the PARTNER trials","volume":"140","author":"Summers","year":"2019","journal-title":"Circulation"},{"key":"B195","doi-asserted-by":"publisher","first-page":"e020368","DOI":"10.1161\/jaha.120.020368","article-title":"Incidence and outcomes of infective endocarditis after transcatheter or surgical aortic valve replacement","volume":"10","author":"Lanz","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2400685","article-title":"Transcatheter or surgical treatment of aortic-valve stenosis","volume":"390","author":"Blankenberg","year":"2024","journal-title":"N Engl J Med"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.049","article-title":"Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial","volume":"76","author":"Pibarot","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.4627","article-title":"Structural valve deterioration after self-expanding transcatheter or surgical aortic valve implantation in patients at intermediate or high risk","volume":"8","author":"O\u2019Hair","year":"2023","journal-title":"JAMA Cardiol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.12.026","article-title":"5-year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial","volume":"13","author":"Abdel-Wahab","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312573","article-title":"Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus","volume":"390","author":"Herrmann","year":"2024","journal-title":"N Engl J Med"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.035150","article-title":"Rate, timing, correlates, and outcomes of hemodynamic valve deterioration after bioprosthetic surgical aortic valve replacement","volume":"138","author":"Salaun","year":"2018","journal-title":"Circulation"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.01.027","article-title":"Determinants of bioprosthetic aortic valve degeneration","volume":"13","author":"Nitsche","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.06.002","article-title":"Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement: JACC state-of-the-art review","volume":"80","author":"Pibarot","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.carpath.2009.09.006","article-title":"Prosthetic valve endocarditis: clinicopathological correlates in 122 surgical specimens from 116 patients (1985-2004)","volume":"20","author":"Lee","year":"2011","journal-title":"Cardiovasc Pathol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jtcvs.2019.09.186","article-title":"Surgical results for prosthetic versus native valve endocarditis: A multicenter analysis","volume":"161","author":"Weber","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2016.1207521","article-title":"Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves","volume":"13","author":"Gallo","year":"2016","journal-title":"Expert Rev Med Devices"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2016.05.055","article-title":"Early and midterm clinical and hemodynamic outcomes of transcatheter valve-in-valve implantation: results from a multicenter experience","volume":"102","author":"D\u2019Onofrio","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.728577","article-title":"Long-term stability and biocompatibility of pericardial bioprosthetic heart valves","volume":"8","author":"Williams","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1161\/01.Cir.0000138947.63799.89","article-title":"Prospectively randomized evaluation of stented xenograft hemodynamic function in the aortic position","author":"Walther","year":"2004","journal-title":"Circulation"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2007.02.062","article-title":"Carpentier-Edwards Perimount Magna valve versus Medtronic Hancock II: a matched hemodynamic comparison","volume":"83","author":"Borger","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.10.060","article-title":"Bovine pericardial versus porcine bioprosthetic aortic valves: A nationwide population-based cohort study in Korea","author":"Kim","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.11.026","article-title":"The many faces of PPARgamma","volume":"123","author":"Lehrke","year":"2005","journal-title":"Cell"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118825376","article-title":"Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes","volume":"16","author":"DeFronzo","year":"2019","journal-title":"Diabetes Vasc Dis Res"},{"key":"B214","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/hypertensionaha.107.099044","article-title":"Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan","volume":"51","author":"Nakamura","year":"2008","journal-title":"Hypertension"},{"key":"B215","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"B216","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.1038\/s41467-022-33202-2","article-title":"Single-cell transcriptomics reveal cellular diversity of aortic valve and the immunomodulation by PPAR\u03b3 during hyperlipidemia","volume":"13","author":"Lee","year":"2022","journal-title":"Nat Commun"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011081","article-title":"PPAR-gamma activation may inhibit the in vivo degeneration of bioprosthetic aortic and aortic valve grafts under diabetic conditions","author":"Katahira","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000001150","article-title":"A role for peroxisome proliferator-activated receptor gamma agonists in counteracting the degeneration of cardiovascular grafts","volume":"79","author":"Assmann","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezad005","article-title":"Impact of PPAR-gamma activation on the durability of biological heart valve prostheses in hypercholesterolaemic rats","author":"Assmann","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1185\/030079906x162746","article-title":"Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes","volume":"23","author":"Pratley","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.04.048","article-title":"Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats","volume":"59","author":"Bao","year":"2014","journal-title":"J Vasc Surg"},{"key":"B222","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2018.18269","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"Jama"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.13772","article-title":"Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial","volume":"322","author":"Rosenstock","year":"2019","journal-title":"Jama"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.117.311588","article-title":"Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors","volume":"122","author":"Scheen","year":"2018","journal-title":"Circ Res"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.116.024270","article-title":"Dipeptidyl peptidase-4 induces aortic valve calcification by inhibiting insulin-like growth factor-1 signaling in valvular interstitial cells","volume":"135","author":"Choi","year":"2017","journal-title":"Circulation"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010057","article-title":"Evogliptin suppresses calcific aortic valve disease by attenuating inflammation, fibrosis, and calcification","author":"Choi","year":"2021","journal-title":"Cells"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317024","article-title":"Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis","volume":"106","author":"Lee","year":"2020","journal-title":"Heart"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1577762\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T04:13:22Z","timestamp":1753848802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1577762\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":227,"alternative-id":["10.3389\/fendo.2025.1577762"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1577762","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"article-number":"1577762"}}